Cancer treatments touch a wide range of values that count for patients and other stakeholders: What are the implications for decision‐making? by Cilla E. J. Vrinzen, Haiko J. Bloemendal, Esra Stuart, Amr Makady, Michel vanAgthoven, Mariska Koster, Matthias A. W. Merkx, Rosella P. M. G. Hermens, Patrick P. T. Jeurissen

Get full text

Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study by Niek A. Peters, Alexander Constantinides, Inge Ubink, Joyce van Kuik, Haiko J. Bloemendal, Haiko J. Bloemendal, Joyce M. van Dodewaard, Menno A. Brink, Thijs P. Schwartz, Martijn P.J.K. Lolkema, Miangela M. Lacle, Leon M. Moons, Joost Geesing, Wilhelmina M.U. van Grevenstein, Jeanine M. L. Roodhart, Jeanine M. L. Roodhart, Miriam Koopman, Sjoerd G. Elias, Inne H.M. Borel Rinkes, Inne H.M. Borel Rinkes, Onno Kranenburg

Get full text

Four-year effects of exercise on fatigue and physical activity in patients with cancer by Lenja Witlox, Anouk E. Hiensch, Miranda J. Velthuis, Charlotte N. Steins Bisschop, Maartje Los, Frans L. G. Erdkamp, Haiko J. Bloemendal, Marlies Verhaar, Daan ten Bokkel Huinink, Elsken van der Wall, Petra H. M. Peeters, Anne M. May

Get full text

Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis by Harm Westdorp, Harm Westdorp, Mark W. D. Sweep, Mark W. D. Sweep, Mark A. J. Gorris, Mark A. J. Gorris, Frank Hoentjen, Frank Hoentjen, Marye J. Boers-Sonderen, Rachel S. van der Post, Michel M. van den Heuvel, Berber Piet, Berber Piet, Annemarie Boleij, Haiko J. Bloemendal, I. Jolanda M. de Vries

Get full text

TripleAiM1: a nationwide registry of de novo metastatic hormone-sensitive prostate cancer with prospective quality-of-life assessment by Sjoerd O Klaver, André N Vis, Gerard Vreugdenhil, Haiko J Bloemendal, Pieter L van den Berg, Niven Mehra, Mathijs P Hendriks, Tessa van Elst, Sjaak Bloem, Zarina Lalmahomed, Daphne Luijendijk, Jean-Paul A van Basten, Roderick CN van den Bergh, Joyce M van Dodewaard-de Jong, Addy CM van de Luijtgaarden, Luc AJ Roelofs, Eric HJEJ Vrijhof, Bart P Wijsman, Peter FA Mulders

Get full text

Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access ProtocolResearch in context by Karlijn Verkerk, Birgit S. Geurts, Laurien J. Zeverijn, Vincent van der Noort, Henk M.W. Verheul, John B.A.G. Haanen, Astrid A.M. van der Veldt, Ferry A.L.M. Eskens, Maureen J.B. Aarts, Carla M.L. van Herpen, Mathilde Jalving, Jourik A. Gietema, Lot A. Devriese, Mariette Labots, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Egbert F. Smit, Haiko J. Bloemendal

Get full text

The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for ‘Trial within Cohorts’ study designs by Hilin Yildirim, Christiaan V Widdershoven, Maureen JB Aarts, Axel Bex, Haiko J Bloemendal, Deirdre M Bochove-Overgaauw, Paul Hamberg, Karin H Herbschleb, Tom van der Hulle, Brunolf W Lagerveld, Martijn GH van Oijen, Sjoukje F Oosting, Johannes V van Thienen, Astrid AM van der Veldt, Hans M Westgeest, Evelijn E Zeijdner, Katja KH Aben, Corina van den Hurk, Patricia J Zondervan, Adriaan D Bins

Get full text